Results 211 to 220 of about 1,137,562 (341)

October 5th 2005 [PDF]

open access: yes, 2005
Hispanic News
core  

A Comparison of Birth Outcomes Among Black, Hispanic, and Black Hispanic Women

open access: yesJournal of Racial and Ethnic Health Disparities, 2015
Phylicia T. Bediako   +2 more
semanticscholar   +1 more source

Effects of Renal and Hepatic Impairment on the Pharmacokinetics of Zilurgisertib

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim Small‐molecule activin receptor‐like kinase‐2 inhibitor zilurgisertib (INCB000928) is under investigation in a pivotal trial for the treatment of fibrodysplasia ossificans progressiva (FOP), an ultrarare genetic condition. This analysis assessed effects of renal and hepatic impairment on zilurgisertib pharmacokinetics.
Yan‐ou Yang   +5 more
wiley   +1 more source

Central corneal thickness in healthy persons and in glaucoma patients in a Colombian population. [PDF]

open access: yesMedUNAB, 2007
Juan Carlos Rueda   +7 more
doaj  

Design and implementation of the Hispanic Community Health Study/Study of Latinos.

open access: yesAnnals of Epidemiology, 2010
P. Sorlie   +12 more
semanticscholar   +1 more source

An open‐label, single‐arm, dose‐escalating concentration–QT study to investigate the cardiac effects and safety of paroxetine in healthy adults

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Paroxetine is a selective serotonin reuptake inhibitor (SSRI), approved for treatment of major depressive disorder and anxiety disorders. Some SSRIs are known to prolong the QT interval; however, clinical evidence to establish a lack of association between paroxetine and corrected QT interval (QTc) prolongation is limited. Therefore, this
Sven C. van Dijkman   +6 more
wiley   +1 more source

April 6th 1994 [PDF]

open access: yes, 1994
Hispanic News
core  

Home - About - Disclaimer - Privacy